SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Notelovitz M 2001 Effects of estrogen/androgen therapy on bone mineral density parameters. J Reprod Med 46 (Suppl 3): 325331.
  • 2
    Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martinez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA 2000 Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 34: 161168.
  • 3
    Goulding A, Gold E 1993 Flutamide-mediated androgen blockade evokes osteopenia in the female rat. J Bone Miner Res 8: 763769.
  • 4
    Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99: 1349813503.
  • 5
    Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y, Nakamichi Y, Metzger D, Chambon P, Nakamura K, Kawaguchi H, Kato S 2003 Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 100: 94169421.
  • 6
    Kang HY, Yeh S, Fujimoto N, Chang C 1999 Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem 274: 85708576.
  • 7
    Kang HY, Lin HK, Hu YC, Yeh S, Huang KE, Chang C 2001 From transforming growth factor-beta signaling to androgen action: Identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc Natl Acad Sci USA 98: 30183023.
  • 8
    Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C 2002 Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277: 4374943756.
  • 9
    Heinlein CA, Chang C 2002 The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16: 21812187.
  • 10
    Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104: 719730.
  • 11
    Pluciennik F, Verrecchia F, Bastide B, Herve JC, Joffre M, Deleze J 1996 Reversible interruption of gap junctional communication by testosterone propionate in cultured Sertoli cells and cardiac myocytes. J Membr Biol 149: 169177.
  • 12
    Kubli-Garfias C, Canchola E, Arauz-Contreras J, Feria-Velasco A 1982 Depressant effect of androgens on the cat brain electrical activity and its antagonism by ruthenium red. Neuroscience 7: 27772782.
  • 13
    Costarella CE, Stallone JN, Rutecki GW, Whittier FC 1996 Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther 277: 3439.
  • 14
    Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F 2000 Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19: 54065417.
  • 15
    Cantley LC 2002 The phosphoinositide 3-kinase pathway. Science 296: 16551657.
  • 16
    Chan TO, Rittenhouse SE, Tsichlis PN 1999 AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 68: 9651014.
  • 17
    Brazil DP, Park J, Hemmings BA 2002 PKB binding proteins. Getting in on the Akt. Cell 111: 293303.
  • 18
    Neri LM, Borgatti P, Capitani S, Martelli AM 2002 The nuclear phosphoinositide 3-kinase/AKT pathway: A new second messenger system. Biochim Biophys Acta 1584: 7380.
  • 19
    Lin HK, Yeh S, Kang HY, Chang C 2001 Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Natl Acad Sci USA 98: 72007205.
  • 20
    Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C 2002 Phosphorylation-dependent ubiquitination and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 21: 40374048.
  • 21
    Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE 1997 The localization of androgen receptors in human bone. J Clin Endocrinol Metab 82: 34933497.
  • 22
    Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC 1989 Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 86: 854857.
  • 23
    Nakano Y, Morimoto I, Ishida O, Fujihira T, Mizokami A, Tanimoto A, Yanagihara N, Izumi F, Eto S 1994 The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells. Bone Miner 26: 245259.
  • 24
    Gruber R, Czerwenka K, Wolf F, Ho GM, Willheim M, Peterlik M 1999 Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor alpha- and beta-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells. Bone 24: 465473.
  • 25
    Lieberherr M, Grosse B 1994 Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem 269: 72177223.
  • 26
    Benten WP, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunderlich F 1999 Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 10: 31133123.
  • 27
    Danciu TE, Adam RM, Naruse K, Freeman MR, Hauschka PV 2003 Calcium regulates the PI3K-Akt pathway in stretched osteoblasts. FEBS Lett 536: 193197.
  • 28
    Yano S, Tokumitsu H, Soderling TR 1998 Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396: 584587.
  • 29
    Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris CE, Mossmann H, Wunderlich F 1999 Functional testosterone receptors in plasma membranes of T cells. FASEB J 13: 123133.
  • 30
    Borgatti P, Martelli AM, Bellacosa A, Casto R, Massari L, Capitani S, Neri LM 2000 Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors. FEBS Lett 477: 2732.
  • 31
    Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR 2003 Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 17: 11061116.
  • 32
    Zhu Y, Bond J, Thomas P 2003 Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100: 22372242.
  • 33
    Zhu Y, Rice CD, Pang Y, Pace M, Thomas P 2003 Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 100: 22312236.
  • 34
    Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298: 843846.
  • 35
    Hofbauer LC, Hicok KC, Khosla S 1998 Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line. J Cell Biochem 71: 96108.
  • 36
    Seino Y 1994 Cytokines and growth factors which regulate bone cell function. Acta Astronaut 33: 131136.
  • 37
    Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S, Russo G, Tsichlis P, Croce CM 2000 Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 97: 30283033.
  • 38
    Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM 2002 PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 11531160.
  • 39
    Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL 2002 PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8: 11451152.
  • 40
    Drissi H, Hushka D, Aslam F, Nguyen Q, Buffone E, Koff A, van Wijnen A, Lian JB, Stein JL, Stein GS 1999 The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts. Cancer Res 59: 37053711.
  • 41
    Lapointe J, Labrie C 2001 Role of the cyclin-dependent kinase inhibitor p27(Kip1) in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation. Endocrinology 142: 43314338.